Nan Fung Group Holdings Ltd

Q3 2026 13F-HR Holdings

Location
Kai Tak, K3
Holdings as of
9/30/2026
Date filed
11/13/2026
Form type
13F-HR
Num holdings
29
Total value ($000)
$149,667
Net value change ($000)
+18,178 (13.8%)
New positions
5
Sold out positions
1
Turnover %
19.1%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
OBSIDIAN THERAPEUTICS INC 12,615 NEW
NUVB 7,432 NEW
HELP 5,607 85.9%
NAMS 4,012 NEW
LBRX 3,737 18.3%
TCGX ACQUISITION CORP 2,502 NEW
PCOR 2,429 112.2%
BRAVEHEART BIO INC 1,644 NEW
ONC 1,273 28.4%
INCY 430 7.1%
Top Reduces (Value $000, Stocks/ETFs)
MPLT -11,370 -32.7%
EVMN -7,248 -37.8%
RXRX -1,435 -65.7%
OCS -1,362 -32.7%
RYTM -777 -14.2%
CELC -711 -24.0%
ACAD -530 -20.3%
Ascendis Pharma AS -529 -14.6%
CHYM -432 -100.0%
MDGL -188 -6.2%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type